(Q39876181)

15 September 2017

title

Analyses of TGF-beta1-inducible Ig germ-line gamma2b promoter activity: involvement of Smads and NF-kappaB. (English)

1 reference

15 September 2017

1 reference

Goo-Young Seo

1

1 reference

15 September 2017

Seok-Rae Park

series ordinal

2

1 reference

15 September 2017

Pyeung-Hyeun Kim

series ordinal

3

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

European Journal of Immunology

15 September 2017

published in

1 reference

15 September 2017

volume

39

1 reference

15 September 2017

issue

4

1 reference

15 September 2017

page(s)

1157-1166

1 reference

Activation of NF-kappaB/Rel by CD40 engagement induces the mouse germ line immunoglobulin Cgamma1 promoter

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

The ability of CD40L, but not lipopolysaccharide, to initiate immunoglobulin switching to immunoglobulin G1 is explained by differential induction of NF-kappaB/Rel proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

Myb and Ets proteins cooperate to transactivate an early myeloid gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type beta-induced isotype switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

AML and Ets proteins regulate the I alpha1 germ-line promoter

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Roles of Ets proteins, NF-kappa B and nocodazole in regulating induction of transcription of mouse germline Ig alpha RNA by transforming growth factor-beta 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

p300 cooperates with Smad3/4 and Runx3 in TGFbeta1-induced IgA isotype expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Shared principles in NF-kappaB signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter: regulation by NF-IL-4, a C/EBP family member and NF-kappa B/p50.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-beta -induced growth inhibition and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Evidence that reactive oxygen species do not mediate NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Transcriptional regulation of the transforming growth factor-beta -inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Smad and AML proteins synergistically confer transforming growth factor beta1 responsiveness to human germ-line IgA genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Regulation of Smad7 promoter by direct association with Smad3 and Smad4.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Receptor-associated Mad homologues synergize as effectors of the TGF-beta response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Smad6 inhibits signalling by the TGF-beta superfamily

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Cloning and expression of the murine Elf-1 cDNA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838732

7 January 2021

Identifiers

DOI

10.1002/EJI.200838732

1 reference

15 September 2017

1 reference